Cite
HARVARD Citation
Spicer, J. et al. (n.d.). 528 Intratumoural treatment with LTX-, an oncolytic peptide immunotherapy, in patients with advanced metastatic disease induces CD8 effector cells and regression in some injected tumours. European journal of cancer. pp. S113-. [Online].